GL1X · GenesisL1 explorer

MolNFT v1 · #195415 · protein

AlphaFold monomer V2.0 prediction for integrin alpha-4 (P13612)

P13612: “AlphaFold monomer V2.0 prediction for integrin alpha-4 (P13612)”. MolNFT v1 #195415 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
P13612
Type
protein
Length
1,032 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x46EfCa788d03A3e879DAcDb96552AB8Bbc7e20b3
UniProt
P13612

Structure

1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein1032—P13612

Compared structures

  • 3V4P · Crystal structure of A4B7 headpiece complexed with Fab act-1 · an experimental structure of the same protein · chain A against C, TM-score 0.54
  • 3V4P · crystal structure of a4b7 headpiece complexed with Fab ACT-1 · an experimental structure of the same protein · chain A against C, TM-score 0.54
  • 3V4V · crystal structure of a4b7 headpiece complexed with Fab ACT-1 and RO0505376 · an experimental structure of the same protein · chain A against A, TM-score 0.52
  • 3V4V · Crystal structure of A4B7 headpiece complexed with Fab act-1 and RO0505376 · an experimental structure of the same protein · chain A against A, TM-score 0.52
  • 4HKC · 14-3-3-zeta in complex with S1011 phosphorylated integrin alpha-4 peptide · an experimental structure of the same protein · chain A against B, TM-score 0.01
  • 4HKC · 14-3-3-zeta in complex with S1011 phosphorylated integrin alpha-4 peptide · an experimental structure of the same protein · chain A against B, TM-score 0.01
  • 5C7Z · AP2 MU2 adaptin C-terminal domain complexed with integrin alpha-4 peptide · an experimental structure of the same protein · chain A against B, TM-score 0.01
  • 5C7Z · AP2 Mu2 adaptin C-terminal domain complexed with integrin alpha-4 peptide · an experimental structure of the same protein · chain A against B, TM-score 0.01

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.